Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer
Status:
Unknown status
Trial end date:
2020-10-16
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, controlled trial to evaluate the efficacy and safety of
Maintenance Treatment with Capecitabine plus Apatinib, Apatinib and Observation after
First-line XELOX/SOX chemotherapy for Patients with Advanced Gastric Cancer